Archives
- 2018-07
- 2018-10
- 2018-11
- 2019-04
- 2019-05
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
-
br Conflict of interest br Introduction Idiopathic left
2019-05-04
Conflict of interest Introduction Idiopathic left ventricular tachycardia (ILVT) with a right bundle-branch block (RBBB) configuration and superior or left axis is a distinct entity that arises in the left ventricle, mostly because of a reentry mechanism and is usually verapamil sensitive [1–6
-
EZ Cap Reagent GG br Conclusion and future directions br Con
2019-04-30
Conclusion and future directions Conflict of interest Acknowledgments Introduction Epithelial-mesenchymal transition (EMT) is a process by which epithelial EZ Cap Reagent GG lose their polarity and are converted to a mesenchymal phenotype; recently, this has been regarded as the critica
-
The patient was consented to
2019-04-30
The patient was consented to treatment on clinical trial NCT02527447 and received treatment with salvage chemotherapy of mitoxantrone 12mg/m2/day IV on days 1–3, etoposide 200mg/m2/day continuous IV infusion (CIV) on days 8–10, and cytarabine 500mg/m2/day CIV on days 1–3 and 8–10 (EMA). Infectious p
-
br Discussion Clinically HES may be
2019-04-30
Discussion Clinically, HES may be separated into two subgroups: HES with, and HES without gene abnormality such as PDGFRA, PDGFRB, or FGFR1. The standard therapy of HES without gene abnormality is steroid; by contrast, the first-line therapy of HES with gene abnormality is imatinib. Although in-
-
br Treatment and follow up recommendations for
2019-04-30
Treatment and follow-up recommendations for patients receiving aromatase inhibitors Conclusions and future directions It is evident that, in addition to BMD, clinical risk factors can greatly influence fracture risk. In addition to morbidity and mortality, fractures are associated with high he
-
En El fistol del diablo Payno construye un argumento o
2019-04-30
En El fistol del diablo Payno construye un argumento o trama que abriga una rencilla entre naciones que se remonta hiv integrase inhibitor la guerra de Texas, con memoria de El Alamo y la batalla de San Jacinto en la que el general Santa Anna es sorprendido y vencido por Sam Houston. La historia se
-
Su acci n en Chiapas fracas no
2019-04-30
Su acción en Chiapas fracasó, no sólo por el rechazo que generó entre los encomenderos sino también entre los religiosos que apoyaban la encomienda en beneficio propio o bien como mecanismo de cristianización acelerado. Cuando Las Casas regresa raltegravir potassium España, en lo que hace a su batal
-
Como tercera cuesti n y de suma relevancia la econom
2019-04-30
Como tercera cuestión, y de suma relevancia, la economía argentina fue receptora de una muy pequeña inversión china, contrariamente dnmt la expectativa generada por la visita al país del presidente Hu Jintao, en noviembre de 2004. Se había supuesto, desde el gobierno argentino, que el eventual desti
-
Este escenario de transformaci n del conflicto en
2019-04-30
Este escenario de transformación del conflicto en Colombia implica que después de firmado el acuerdo se trabaje, primero, en el triángulo del conflicto que logre la superación de la violencia directa, estructural y cultural en Colombia y, segundo, sobre el triángulo del conflicto que implica las 3R
-
isosafrole What should clinicians tell high risk cardiovascu
2019-04-29
What should clinicians tell high-risk cardiovascular patients about air pollution? To date, management guidelines provide little or no guidance. A recent workshop hosted by the European Respiratory Society addressed this question and identified two major areas that should be considered by future gui
-
br Relationship among ICD shocks substrate and mortality
2019-04-29
Relationship among ICD shocks, substrate, and mortality There is a strong correlation between ICD-shocked spontaneous VTAs and subsequent mortality [5,6]. Patients who receive inappropriate shocks are also at an increased risk of mortality, although the magnitude of this increase is smaller [5,6]
-
In patients with systolic heart failure and a wide QRS
2019-04-29
In patients with systolic heart failure and a wide QRS complex, cardiac resynchronisation therapy (CRT) using left ventricular (LV) pacing has been shown to enhance survival, reduce heart failure hospitalisation and enhance exercise capacity in patients with all mao inhibitor of heart failure. The
-
br TAMs role in bone
2019-04-29
TAMs\' role in bone metastasis and primary bone cancer: evidence from preclinical and clinical studies The majority of preclinical and clinical studies assess TAMs in primary tumours and metastasis-associated macrophages (MAMs) in visceral metastases (e.g. lung, liver, kidney, spleen, brain). Som
-
br Conclusion br Level of evidence
2019-04-29
Conclusion Level of evidence: IV Patients and methods We analyzed the survival, local recurrence, and distant metastasis outcomes using survivorship techniques. Duration of symptoms was analyzed with t-test of student. We used Kaplan–Meier survival analysis to determine the cumulative proba
-
Remote AF detection by a previously reported event recorder
2019-04-29
Remote AF detection by a previously reported event recorder is predominantly accomplished by R-R interval analysis, because atrial signal recognition with conventional monitoring devices is difficult. As a result, some patients with organized AF or atrial flutter might be misdiagnosed. CardioBlip is
15150 records 979/1010 page Previous Next First page 上5页 976977978979980 下5页 Last page